Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Podlipnik

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Acta Dermato-Venereologica|December 13, 2022
Diagnostic Accuracy of Image-guided Biopsies for Diagnosis of Metastatic Melanoma in a Real-life SettingLaura Serra-García, Jesica Eliana-Radonich, Ignasi Marti-Marti, et al.
Cancers|March 10, 2022
Timeline of Adverse Events during Immune Checkpoint Inhibitors for Advanced Melanoma and Their Impacts on SurvivalLorena Villa-Crespo, Sebastian Podlipnik, Natalia Anglada, et al.
Acta Dermato-Venereologica|February 29, 2020
Microblotches on Dermoscopy of Melanocytic Lesions are Associated with Melanoma: A Cross-sectional StudyVania Lukoviek, Nuria Ferrera, Sebastian Podlipnik, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 25, 2023
Analysis of dermoscopic changes of blue nevi on digital follow-up: A 21-year retrospective cohort studyFrancesc Alamon-Reig, Marc Combalia, Raquel Albero-González, et al.
Journal of the American Academy of Dermatology|May 18, 2016
Performance of diagnostic tests in an intensive follow-up protocol for patients with American Joint Committee on Cancer (AJCC) stage IIB, IIC, and III localized primary melanoma: A prospective cohort studySebastian Podlipnik, Cristina Carrera, Marcelo Sánchez, et al.
Cancers|June 27, 2024
Predictive and Prognostic Factors in Melanoma Central Nervous System Metastases-A Cohort StudyEstefania Serra, Álvaro Abarzua-Araya, Ana Arance, et al.
Journal of the American Academy of Dermatology|October 20, 2022
Prognostic role of microsatellites in melanoma and implications in the American Joint Committee on Cancer classification system: A cohort studyConstanza Riquelme-Mc Loughlin, Alejandra Sandoval-Clavijo, María Blanco de Tord, et al.
The British Journal of Dermatology|June 14, 2022
Common genetic variants associated with melanoma risk or naevus count in patients with wildtype MC1R melanomaNeus Calbet-Llopart, Marc Combalia, Anil Kiroglu, et al.
Molecular Oncology|July 9, 2024
PRRX1 silencing is required for metastatic outgrowth in melanoma and is an independent prognostic of reduced survival in patientsJosep R Ferreres, Antònia Vinyals, Rafael Campos-Martin, et al.
The Journal of Investigative Dermatology|February 8, 2026
Exploring global cfDNA fragmentomics as a biomarker in real-world melanoma patientsDaniel Rizo-Potau, Anton Forniés-Mariné, José Luis Villanueva-Cañas, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Acta Dermato-Venereologica|December 13, 2022
Diagnostic Accuracy of Image-guided Biopsies for Diagnosis of Metastatic Melanoma in a Real-life SettingLaura Serra-García, Jesica Eliana-Radonich, Ignasi Marti-Marti, et al.
Cancers|March 10, 2022
Timeline of Adverse Events during Immune Checkpoint Inhibitors for Advanced Melanoma and Their Impacts on SurvivalLorena Villa-Crespo, Sebastian Podlipnik, Natalia Anglada, et al.
Acta Dermato-Venereologica|February 29, 2020
Microblotches on Dermoscopy of Melanocytic Lesions are Associated with Melanoma: A Cross-sectional StudyVania Lukoviek, Nuria Ferrera, Sebastian Podlipnik, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 25, 2023
Analysis of dermoscopic changes of blue nevi on digital follow-up: A 21-year retrospective cohort studyFrancesc Alamon-Reig, Marc Combalia, Raquel Albero-González, et al.
Journal of the American Academy of Dermatology|May 18, 2016
Performance of diagnostic tests in an intensive follow-up protocol for patients with American Joint Committee on Cancer (AJCC) stage IIB, IIC, and III localized primary melanoma: A prospective cohort studySebastian Podlipnik, Cristina Carrera, Marcelo Sánchez, et al.
Cancers|June 27, 2024
Predictive and Prognostic Factors in Melanoma Central Nervous System Metastases-A Cohort StudyEstefania Serra, Álvaro Abarzua-Araya, Ana Arance, et al.
Journal of the American Academy of Dermatology|October 20, 2022
Prognostic role of microsatellites in melanoma and implications in the American Joint Committee on Cancer classification system: A cohort studyConstanza Riquelme-Mc Loughlin, Alejandra Sandoval-Clavijo, María Blanco de Tord, et al.
The British Journal of Dermatology|June 14, 2022
Common genetic variants associated with melanoma risk or naevus count in patients with wildtype MC1R melanomaNeus Calbet-Llopart, Marc Combalia, Anil Kiroglu, et al.
Molecular Oncology|July 9, 2024
PRRX1 silencing is required for metastatic outgrowth in melanoma and is an independent prognostic of reduced survival in patientsJosep R Ferreres, Antònia Vinyals, Rafael Campos-Martin, et al.
The Journal of Investigative Dermatology|February 8, 2026
Exploring global cfDNA fragmentomics as a biomarker in real-world melanoma patientsDaniel Rizo-Potau, Anton Forniés-Mariné, José Luis Villanueva-Cañas, et al.
Pageof 6